Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001973141-24-000211
Filing Date
2024-04-03
Accepted
2024-04-03 16:02:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3458
  Complete submission text file 0001973141-24-000211.txt   4971
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Subject) CIK: 0001556263 (see all company filings)

EIN.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37813 | Film No.: 24818607
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SYROS PHARMACEUTICALS, INC. 620 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Roth David (Reporting) CIK: 0001599014 (see all company filings)

Type: 144